Long-Term Outcomes For Stage I-II Diffuse Large B-Cell Lymphoma Treated With Rituximab And Chemotherapy With Or Without Radiotherapy

Authors :: Sheren F. Younes
K. Wignarajah
Ranjana H. Advani
Michael S. Binkley
Michael C. Jin
Christopher H. Yoo
Richard T. Hoppe
H. Henry Guo
Yasodha Natkunam
Susan M. Hiniker
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:e758
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Radiation
business.industry
medicine.medical_treatment
medicine.disease
Stage i ii
Radiation therapy
Internal medicine
medicine
Long term outcomes
Radiology, Nuclear Medicine and imaging
Rituximab
business
Diffuse large B-cell lymphoma
medicine.drug

Full Text Access

Tools